Delayed administration of alpha-melanocyte-stimulating hormone or combined therapy with BAY 11-7085 protects against gut ischemia-reperfusion injury.

Shock (Augusta, Ga.)

Volumn 20, Issue 5, 2003, Pages 469-475

  Zou, Lei ^a   Sato, Norio ^a   Attuwaybi, Bashir O ^a   Kone, Bruce C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ANTIINFECTIVE AGENT; BAY 11 7085; BAY 11-7085; DNA; HEME OXYGENASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NITRILE; PEROXIDASE; SULFONE;

ANIMAL; ARTICLE; DRUG COMBINATION; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; ILEUM; MALE; METABOLISM; PATHOLOGY; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ALPHA-MSH; ANIMALS; ANTI-INFECTIVE AGENTS; BLOTTING, WESTERN; DNA; DRUG THERAPY, COMBINATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; ILEUM; INTERLEUKIN-6; MALE; NF-KAPPA B; NITRILES; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SULFONES;

EID: 2942636223     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000091205.08003.fd     Document Type: Article

References (0)